
Soft Tissue Repair Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 4 more
- Year: 2022
- Scope: 10 Years
- Region: United States
- Pages: 306
- Published Date: 06/17/2022
- Type: MedSuite
In 2021, the U.S. Soft Tissue Repair Market was valued at $2.4 billion. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $3.8 billion.
The full report suite on the U.S. market for soft tissue repair includes breast reconstruction, hernia repair, dural repair, dental soft tissue regeneration, nerve repair and cardiovascular patch repair.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value &Growth Trends
- Procedure Volumes
- 10 Year Scope
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
U.S. SOFT TISSUE REPAIR MARKET TRENDS
The changing demographics in the U.S. has a very favorable effect on the soft tissue repair market. The growing elderly and obese populations have a higher risk of a number of different medical conditions, including hernias and nerve damage. Between 2010 and 2025, the total number of people with diabetes in the U.S. is expected to increase by 64%. Furthermore, the percentage of the U.S. population that is older than 65 will rise from 15.2% in 2016 to 23.4% in 2034, to reach almost 80 million.
COVID-19 IMPACT ON THE U.S. SOFT TISSUE REPAIR MARKET
The effects of the pandemic on the soft tissue repair market are expected to vary by market segment. Due to the halt in non-urgent procedures and elective surgeries, the pandemic has adversely affected certain soft tissue repair markets. This ultimately limits sales of soft tissue repair products to hospitals and its use in procedures. In most segments of soft tissue repair, procedures are non-life-threatening and are elective surgeries, which adversely affects the market. However, for certain markets, such as the cardiovascular patch repair market, the impacts of COVID-19 were minimal due to the severity and life-threatening nature of cardiovascular disease.
U.S. SOFT TISSUE REPAIR MARKET SHARE INSIGHTS
Overall, within the U.S. soft tissue repair market there are three dominant competitors: Becton Dickinson (BD), AbbVie, and Integra Lifesciences.Becton Dickinson (BD) secured a leading position in the total market. This is because of the company’s broad range of hernia repair products, which allowed it to be the top player in this market. BD’s innovative resorbable synthetic product, Phasix®, was one of the highest-selling products in the market.
MARKET SEGMENTATION SUMMARY
- Procedure Volumes for Soft Tissue Repair Devices – MedPro – The complete procedural analysis for the US Soft Tissue Repair market.
- Breast Reconstruction Market – MedCore – This market contains Allograft, Xenograft and Synthetic Breast Reconstruction Material segments.
- Hernia Repair Market – MedCore – Detailed analysis of the Hernia Repair Market. This includes Ventral, Inguinal, and Hiatal products.
- Dural Repair Market – MedCore – In-depth analysis of the Dural Repair Market. This includes Allograft, Xenograft and Synthetic Material market segments.
- Dental Soft Tissue Repair Market – MedCore – An analysis of the Dental Soft Tissue Repair Market, including Regeneration and Wound Care products.
- Nerve Repair Market – MedCore – In-depth analysis of the Nerve Repair Market, including Wrap, Tube, and Graft products.
- Cardiovascular Repair Market – MedCore – This market is comprised primarily of Cardiac Patch and Vascular Patch products.
Research Scope Summary
Report Attribute | Details |
---|---|
Regions | United States |
Base Year | 2021 |
Forecast | 2022-2028 |
Historical Data | 2018-2021 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
Table of Contents
TABLE of CONTENTS |
List of Figures |
List of Charts |
executive summary |
U.S. Soft Tissue Repair Market Overview |
Competitive Analysis |
Market Trends |
Market Developments |
Procedure Numbers |
Procedure Codes Investigated |
Markets Included |
Key Report Updates |
Version History |
research methodology |
Step 1: Project Initiation & Team Selection |
Step 2: Prepare Data Systems and Perform Secondary Research |
Step 3: Preparation for Interviews & Questionnaire Design |
Step 4: Performing Primary Research |
Step 5: Research Analysis: Establishing Baseline Estimates |
Step 6: Market Forecast and Analysis |
Step 7: Identify Strategic Opportunities |
Step 8: Final Review and Market Release |
Step 9: Customer Feedback and Market Monitoring |
impact of covid-19 on THE U.S. Soft Tissue Repair Market |
2.1 Introduction |
2.2 Analysis By Market Segment |
2.2.1 Worst Case Scenario |
2.2.2 Base Case Scenario |
2.2.3 Best Case Scenario |
Disease Overview |
3.1 Basic Anatomy |
3.2 Disease Treatment and Diagnostic |
3.2.1 Breast Cancer |
3.2.2 Cardiovascular Tissue Repair |
3.2.3 Dental Soft Tissue Disease |
3.2.4 Dural Tears and Cerebrospinal Fluid Leakage Prevention |
3.2.5 Hernia |
3.2.6 Peripheral Vasculature Repair |
3.2.7 Traumas and Burns |
3.3 Patient Demographics |
3.3.1 Breast Cancer Statistics |
3.3.2 Cardiovascular Disease Statistics |
3.3.3 Hernia Repair Statistics |
3.3.4 Periodontitis Statistics |
3.3.5 Peripheral Vascular Disease (PVD) Statistics |
3.3.6 Traumatic and Sport-Related Injuries Statistics |
Product Assessment |
4.1 Introduction |
4.2 Product Portfolios |
4.2.1 Breast Reconstruction Market |
4.2.2 Hernia Repair Market |
4.2.3 Dural Repair Market |
4.2.4 Dental Soft Tissue Regeneration Market |
4.2.5 Nerve Repair Market |
4.2.6 Cardiovascular Repair |
4.3 Regulatory Issues and Recalls |
4.3.1 Hernia Repair |
4.3.2 Dural Repair |
4.3.3 Cardiovascular Repair |
4.4 Clinical Trials |
4.4.1 Breast Reconstruction |
4.4.2 Hernia Repair |
4.4.3 Dural Repair |
4.4.4 Dental Soft Tissue Regeneration |
4.4.5 Nerve Repair |
U.S. Soft Tissue Repair Market Overview |
5.1 Introduction |
5.2 Market Overview & Trend Analysis |
5.3 Drivers and Limiters |
5.3.1 Market Drivers |
5.3.2 Market Limiters |
5.4 Competitive Market Share Analysis |
5.5 Mergers and Acquisitions |
5.6 Company Profiles |
5.6.1 Axogen |
5.6.2 AbbVie |
5.6.3 Artivion |
5.6.4 Becton Dickinson |
5.6.5 W.L. Gore |
5.6.6 Integra LifeSciences |
5.6.7 Johnson and Johnson |
5.6.7.1 DePuy Synthes |
5.6.7.2 Ethicon |
5.6.8 LeMaitre Vascular |
5.6.9 Medtronic |
5.6.10 MTF Biologics |
5.6.11 Stryker |
5.6.12 Zimmer Biomet (ZimVie) |
5.7 SWOT Analysis |
5.7.1 Axogen |
5.7.2 AbbVie |
5.7.3 Artivion |
5.7.4 Becton Dickinson |
5.7.5 DePuy Synthes |
5.7.6 Ethicon |
5.7.7 W.L. Gore |
5.7.8 Integra LifeSciences |
5.7.9 LeMaitre Vascular |
5.7.10 Medtronic |
5.7.11 MTF Biologics |
5.7.12 Stryker |
5.7.13 Zimmer Biomet (ZimVie) |
Procedure Numbers |
6.1 Introduction |
6.2 Procedures |
6.2.1 Breast Reconstruction Procedures |
6.2.1.1 Breast Reconstruction Procedures by Method |
6.2.1.1.1 Implant-Based Breast Reconstruction Procedures |
6.2.1.1.2 Autologous Breast Reconstruction Procedures |
6.2.1.2 Breast Reconstruction Procedures by Care Setting |
6.2.2 Hernia Repair Procedures |
6.2.2.1 Hernia Repair Procedures by Type |
6.2.2.2 Hernia Repair Procedures by Care Setting |
6.2.2.3 Hernia Repair Procedures by Robotic Assistance |
6.2.3 Dural Repair Procedures |
6.2.4 Dental Soft Tissue Regeneration Procedures |
6.2.5 Cardiovascular Patch Repair Procedures |
6.2.6 Nerve Repair Procedures |
Breast Reconstruction Market |
7.1 Introduction |
7.2 Market Overview |
7.2.1 Breast Reconstruction Market by Material Type |
7.2.2 Breast Reconstruction Market by Care Setting |
7.3 Market Analysis and Forecast |
7.3.1 Breast Reconstruction Market |
7.3.2 Allograft Breast Reconstruction Market |
7.3.3 Xenograft Breast Reconstruction Market |
7.3.4 Synthetic Breast Reconstruction Market |
7.3.5 Breast Reconstruction Market by Care Setting |
7.3.5.1 Hospital Breast Reconstruction Market |
7.3.5.2 Non-Hospital Breast Reconstruction Market |
7.4 Drivers and Limiters |
7.4.1 Market Drivers |
7.4.2 Market Limiters |
7.5 Competitive Market Share Analysis |
hernia Repair Market |
Introduction |
Market Overview |
8.1.1 Hernia Repair Market Overview by Segment |
8.1.2 Hernia Repair Market Overview by Material |
Market Analysis and Forecast |
8.1.3 Hernia Repair Market |
8.1.4 Ventral Hernia Repair Market |
8.1.4.1 Allograft Ventral Hernia Repair Market |
8.1.4.2 Xenograft Ventral Hernia Repair Market |
8.1.4.2.1 Reinforced Xenograft Ventral Hernia Repair Market |
8.1.4.2.2 Non-Reinforced Xenograft Ventral Hernia Repair Market |
8.1.4.3 Synthetic Ventral Hernia Repair Market |
8.1.4.3.1 Resorbable Synthetic Ventral Hernia Repair Market |
8.1.4.3.2 Non-Resorbable Synthetic Ventral Hernia Repair Market |
8.1.4.4 Ventral Hernia Repair Market by Care Setting |
8.1.4.4.1 Hospital Ventral Hernia Repair Market |
8.1.4.4.2 Non-Hospital Ventral Hernia Repair Market |
8.1.5 Inguinal Hernia Repair Market |
8.1.5.1 Allograft Inguinal Hernia Repair Market |
8.1.5.2 Xenograft Inguinal Hernia Repair Market |
8.1.5.3 Synthetic Inguinal Hernia Repair Market |
8.1.5.4 Inguinal Hernia Repair Market by Care Setting |
8.1.5.4.1 Hospital Inguinal Hernia Repair Market |
8.1.5.4.2 Non-Hospital Inguinal Hernia Repair Market |
8.1.6 Hiatal Hernia Repair Market |
8.1.6.1 Allograft Hiatal Hernia Repair Market |
8.1.6.2 Xenograft Hiatal Hernia Repair Market |
8.1.6.2.1 Reinforced Xenograft Hiatal Hernia Repair Market |
8.1.6.2.2 Non-Reinforced Xenograft Hiatal Hernia Repair Market |
8.1.6.3 Synthetic Hiatal Hernia Repair Market |
8.1.6.3.1 Resorbable Synthetic Hiatal Hernia Repair Market |
8.1.6.3.2 Non-Resorbable Synthetic Hiatal Hernia Repair Market |
8.1.6.4 Hiatal Hernia Repair Market by Care Setting |
8.1.6.4.1 Hospital Hiatal Hernia Repair Market |
8.1.6.4.2 Non-Hospital Hiatal Hernia Repair Market |
8.2 Drivers and Limiters |
8.2.1 Market Drivers |
8.2.2 Market Limiters |
8.3 Competitive Market Share Analysis |
Dural Repair Market |
9.1 Introduction |
9.2 Market Overview |
9.2.1 Dural Repair Market by Material Type |
9.2.2 Dural Repair Market by Care Setting |
9.3 Market Analysis and Forecast |
9.3.1 Dural Repair Market |
9.3.2 Dural Repair Market by Material Type |
9.3.2.1 Allograft Dural Repair Market |
9.3.2.2 Xenograft Dural Repair Market |
9.3.2.3 Synthetic Dural Repair Market |
9.3.3 Dural Repair Market by Care Setting |
9.3.3.1 Hospital Dural Repair Market |
9.3.3.2 Non-Hospital Dural Repair Market |
9.4 Drivers and Limiters |
9.4.1 Market Drivers |
9.4.2 Market Limiters |
9.5 Competitive Market Share Analysis |
dental soft tissue regeneration Market |
Introduction |
Market Overview |
10.1 Market Analysis and Forecast |
10.1.1 Dental Soft Tissue Regeneration Market |
10.1.2 Allograft Dental Soft Tissue Regeneration Market |
10.1.3 Xenograft Dental Soft Tissue Regeneration Market |
10.1.4 Dental Wound Care Market |
10.1.4.1 Plug Dental Wound Care Market |
10.1.4.2 Tape Dental Wound Care Market |
10.1.4.3 Foam Dental Wound Care Market |
10.2 Drivers and Limiters |
10.2.1 Market Drivers |
10.2.2 Market Limiters |
10.3 Competitive Market Share Analysis |
Nerve Repair Market |
11.1 Introduction |
11.2 Market Overview |
11.2.1 Nerve Repair Market by Product Type |
11.2.2 Nerve Repair Market by Care Setting |
11.3 Market Analysis and Forecast |
11.3.1 Nerve Repair Market |
11.3.2 Nerve Repair Market by Product Type |
11.3.2.1 Nerve Wrap Market |
11.3.2.2 Nerve Graft Market |
11.3.2.3 Nerve Tube Market |
11.3.2.4 Nerve Cap Market |
11.3.3 Nerve Repair Market by Care Setting |
11.3.3.1 Hospital Nerve Repair Market |
11.3.3.2 Non-Hospital Nerve Repair Market |
11.4 Drivers and Limiters |
11.4.1 Market Drivers |
11.4.2 Market Limiters |
11.5 Competitive Market Share Analysis |
Cardiovascular Patch Repair Market |
12.1 Introduction |
12.2 Market Overview |
12.2.1 Cardiovascular Patch Repair Market Overview by Segment |
12.2.2 Cardiovascular Patch Repair Market Overview by Material |
12.3 Market Analysis and Forecast |
12.3.1 Cardiovascular Patch Repair Market |
12.3.2 Cardiac Patch Market |
12.3.2.1 Allograft Cardiac Patch Market |
12.3.2.2 Xenograft Cardiac Patch Market |
12.3.2.3 Synthetic Cardiac Patch Market |
12.3.3 Vascular Patch Market |
12.3.3.1 Xenograft Vascular Patch Market |
12.3.3.2 Synthetic Vascular Patch Market |
12.4 Drivers and Limiters |
12.4.1 Market Drivers |
12.4.2 Market Limiters |
12.5 Competitive Market Share Analysis |
Abbreviations |
Companies Included:
· Abbott | · Geistlich Pharma |
· AbbVie | · Getinge |
· ACE Surgical | · Henry Schein |
· Admedus | · Integra LifeSciences |
· Alafair Biosciences | · LeMaitre Vascular |
· Artivion | · LifeNet Health |
· Axogen | · Mast Biosurgery |
· Aziyo Biologics | · Medtronic |
· Baxter | · MTF Biologics |
· B. Braun | · Natus Medical |
· Becton Dickinson | · Novus Scientific |
· Bioventus | · Osteogenics |
· Checkpoint Surgical | · Reprise Biomedical |
· Citagenix | · RTI Surgical |
· Collagen Matrix | · Straumann |
· Cook Medical | · Stryker |
· CorMatrix | · Synertech Medical |
· Deep Blue | · TELA Bio |
· DePuy Synthes | · Tissue Regenix |
· DynaMesh | · W.L. Gore |
· Edwards LifeSciences | · XTANT Medical |
· Ethicon | · Zimmer Biomet (ZimVie) |
List of Charts
Chart 1‑1: Soft Tissue Repair Market by Segment, U.S., 2021 – 2028 |
Chart 1‑2: Soft Tissue Repair Market Overview, U.S., 2021 & 2028 |
Chart 2‑1: Multi-Scenario Soft Tissue Repair Market Forecast, U.S., 2018 – 2028 (US$M) |
Chart 5‑1: Soft Tissue Repair Market by Segment, U.S., 2018 – 2028 |
Chart 5‑2: Leading Competitors, Soft Tissue Repair Market, U.S., 2021 |
Chart 6‑1: Soft Tissue Repair Procedures by Segment, U.S., 2018 – 2028 |
Chart 7‑1: Breast Reconstruction Market by Material Type, U.S., 2018 – 2028 |
Chart 7‑2: Breast Reconstruction Market by Care Setting, U.S., 2018 – 2028 |
Chart 7‑3: Leading Competitors, Breast Reconstruction Market, U.S., 2021 |
Chart 8‑1: Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Chart 8‑2: Hernia Repair Market by Material, U.S., 2018 – 2028 |
Chart 8‑3: Leading Competitors, Hernia Repair Market, U.S., 2021 |
Chart 9‑1: Dural Repair Market by Material Type, U.S., 2018 – 2028 |
Chart 9‑2: Dural Repair Market by Care Setting, U.S., 2018 – 2028 |
Chart 9‑3: Leading Competitors, Dural Repair Market, U.S., 2021 |
Chart 10‑1: Dental Soft Tissue Regeneration Market by Segment, U.S., 2018 – 2028 |
Chart 10‑2: Leading Competitors, Dental Soft Tissue Regeneration Market, U.S., 2021 |
Chart 11‑1: Nerve Repair Market by Segment, U.S., 2018 – 2028 |
Chart 11‑2: Nerve Repair Market by Care Setting, U.S., 2018 – 2028 |
Chart 11‑3: Leading Competitors, Nerve Repair Market, U.S., 2021 |
Chart 12‑1: Cardiovascular Patch Repair Market by Segment, U.S., 2018 – 2028 |
Chart 12‑2: Cardiovascular Patch Repair Market by Material, U.S., 2018 – 2028 |
Chart 12‑3: Leading Competitors, Cardiovascular Patch Market, U.S., 2021 |
List of Figures
Figure 1‑1: Soft Tissue Repair Market Share Ranking by Segment, U.S., 2021 |
Figure 1‑2: Companies Researched in this Report |
Figure 1‑3: Factors Impacting the Soft Tissue Repair Market by Segment, U.S. |
Figure 1‑4: Recent Events in the Soft Tissue Repair Market, U.S., 2018 – 2022 (1 of 2) |
Figure 1‑5: Recent Events in the Soft Tissue Repair Market, U.S., 2018– 2022 (2 of 2) |
Figure 1‑6: Soft Tissue Repair Procedures Covered (1 of 2) |
Figure 1‑7: Soft Tissue Repair Procedures Covered (2 of 2) |
Figure 1‑8: Procedure Codes Investigated |
Figure 1‑9: Soft Tissue Repair Markets Covered (1 of 3) |
Figure 1‑10: Soft Tissue Repair Markets Covered (2 of 3) |
Figure 1‑11: Soft Tissue Repair Markets Covered (3 of 3) |
Figure 1‑12: Key Report Updates |
Figure 1‑13: Version History |
Figure 2‑1: Soft Tissue Repair Market by Segment, Worst Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 2‑2: Soft Tissue Repair Market by Segment, Base Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 2‑3: Soft Tissue Repair Market by Segment, Best Case Scenario, U.S., 2018 – 2028 (US$M) |
Figure 4‑1: Breast Reconstruction Products Market by Company |
Figure 4‑2: Hernia Repair Market Products by Company (1 of 2) |
Figure 4‑3: Hernia Repair Market Products by Company (2 of 2) |
Figure 4‑4: Dural Repair Market Products by Company |
Figure 4‑5: Dental Soft Tissue Regeneration Market by Company |
Figure 4‑6: Nerve Repair Market by Company |
Figure 4‑7: Cardiovascular Repair Market by Company |
Figure 4‑8: Class 2 Device Recall VERITAS Collagen Matrix |
Figure 4‑9: Class 2 Device Recall Proceed Surgical Mesh |
Figure 4‑10: Class 2 Device Recall Gentrix Surgical Matrix Thick |
Figure 4‑11: Class 2 Device Recall DuraMatrix Collagen Dura Substitute Membranes |
Figure 4‑12: Class 2 Device Recall DuraMatrix Collagen Dura Substitute Membranes |
Figure 4‑13: Class 2 Device Recall CryoPatch SG Pulmonary Human Cardiac Patch |
Figure 4‑14: Evaluation of ADM Soft Tissue Reinforcement |
Figure 4‑15: Biosynthetic Absorbable Mesh vs Standard of Repair for the Surgical Treatment of Infected Incisional Hernia (COMpACT-BIO) |
Figure 4‑16: Mesh Type in Ventral Hernia Repair |
Figure 4‑17: Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair (PPDS) |
Figure 4‑18: A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair |
Figure 4‑19: Clinical Study on the Safety of SAFIL® MESH |
Figure 4‑20: Biologic Mesh Versus Synthetic Mesh in Repair of Ventral Hernias (ventral hernia) |
Figure 4‑21: A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. |
Figure 4‑22: To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure |
Figure 4‑23 TISSIUM™ Nerve Coaptation Device First-in-Human Clinical Trial: |
Figure 4‑24: Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair (RECON) |
Figure 4‑25: Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction (RANGER®) |
Figure 5‑1: Soft Tissue Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 5‑2: Leading Competitors, Soft Tissue Repair Market, U.S., 2021 |
Figure 5‑3: SWOT Analysis, Axogen |
Figure 5‑4: SWOT Analysis, AbbVie |
Figure 5‑5: SWOT Analysis, Artivion |
Figure 5‑6: SWOT Analysis, Becton Dickinson |
Figure 5‑7: SWOT Analysis, DePuy Synthes |
Figure 5‑8: SWOT Analysis, Ethicon |
Figure 5‑9: SWOT Analysis, W.L. Gore |
Figure 5‑10: SWOT Analysis, Integra LifeSciences |
Figure 5‑11: SWOT Analysis, LeMaitre Vascular |
Figure 5‑12: SWOT Analysis, Medtronic |
Figure 5‑13: SWOT Analysis, MTF Biologics |
Figure 5‑14: SWOT Analysis, Stryker |
Figure 5‑15: SWOT Analysis, Zimmer Biomet (ZimVie) |
Figure 6‑1: Procedure Codes Investigated, U.S., 2021 |
Figure 6‑2: Soft Tissue Repair Procedures by Segment, U.S., 2018 – 2028 |
Figure 6‑3: Breast Reconstruction Procedures by Method, U.S., 2018 – 2028 |
Figure 6‑4: Implant-Based Breast Reconstruction Procedures by Method, U.S., 2018 – 2028 |
Figure 6‑5: Implant-Based Breast Reconstruction Procedures by Timing, U.S., 2018 – 2028 |
Figure 6‑6: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑7: Implant-Based Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑8: Implant-Based Breast Reconstruction Procedures by Devices Used, U.S., 2018 – 2028 |
Figure 6‑9: Autologous Breast Reconstruction Procedures by Timing, U.S., 2018 – 2028 |
Figure 6‑10: Autologous Breast Reconstruction Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑11: Breast Reconstruction Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑12: Hernia Repair Procedures by Type, U.S., 2018 – 2028 |
Figure 6‑13: Hernia Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑14: Hernia Repair Procedures by Robotic Assistance, U.S., 2018 – 2028 |
Figure 6‑15: Dural Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 6‑16: Dental Soft Tissue Procedures, U.S., 2018 – 2028 |
Figure 6‑17: Cardiovascular Patch Repair Procedures, U.S., 2018 – 2028 |
Figure 6‑18: Nerve Repair Procedures by Care Setting, U.S., 2018 – 2028 |
Figure 7‑1: Breast Reconstruction Market by Material Type, U.S., 2018 – 2028 (US$M) |
Figure 7‑2: Breast Reconstruction Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 7‑3: Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑4: Allograft Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑5: Xenograft Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑6: Synthetic Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑7: Hospital Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑8: Non-Hospital Breast Reconstruction Market, U.S., 2018 – 2028 |
Figure 7‑9: Leading Competitors, Breast Reconstruction Market, U.S., 2021 |
Figure 8‑1: Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑2: Hernia Repair Market by Material, U.S., 2018 – 2028 (US$M) |
Figure 8‑3: Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑4: Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑5: Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑6: Allograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑7: Xenograft Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑8: Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑9: Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑10: Non-Reinforced Xenograft Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑11: Synthetic Ventral Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑12: Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑13: Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑14: Non-Resorbable Synthetic Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑15: Ventral Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑16: Hospital Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑17: Non-Hospital Ventral Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑18: Inguinal Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑19: Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑20: Allograft Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑21: Xenograft Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑22: Synthetic Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑23: Inguinal Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑24: Hospital Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑25: Non-Hospital Inguinal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑26: Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 8‑27: Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑28: Allograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑29: Xenograft Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑30: Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑31: Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑32: Non-Reinforced Xenograft Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑33: Synthetic Hiatal Hernia Repair Market by Segment, U.S., 2018 – 2028 |
Figure 8‑34: Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑35: Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑36: Non-Resorbable Synthetic Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑37: Hiatal Hernia Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 8‑38: Hospital Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑39: Non-Hospital Hiatal Hernia Repair Market, U.S., 2018 – 2028 |
Figure 8‑40: Leading Competitors, Hernia Repair Market, U.S., 2021 |
Figure 9‑1: Dural Repair Market by Material Type, U.S., 2018 – 2028 (US$M) |
Figure 9‑2: Dural Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 9‑3: Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑4: Allograft Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑5: Xenograft Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑6: Synthetic Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑7: Hospital Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑8: Non-Hospital Dural Repair Market, U.S., 2018 – 2028 |
Figure 9‑9: Leading Competitors, Dural Repair Market, U.S., 2021 |
Figure 10‑1: Dental Soft Tissue Regeneration Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 10‑2: Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑3: Allograft Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑4: Xenograft Dental Soft Tissue Regeneration Market, U.S., 2018 – 2028 |
Figure 10‑5: Dental Wound Care Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 10‑6: Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑7: Plug Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑8: Tape Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑9: Foam Dental Wound Care Market, U.S., 2018 – 2028 |
Figure 10‑10: Leading Competitors, Dental Soft Tissue Regeneration Market, U.S., 2021 |
Figure 11‑1: Nerve Repair Market by Product Type, U.S., 2018 – 2028 (US$M) |
Figure 11‑2: Nerve Repair Market by Care Setting, U.S., 2018 – 2028 (US$M) |
Figure 11‑3: Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑4: Nerve Wrap Market, U.S., 2018 – 2028 |
Figure 11‑5: Nerve Graft Market, U.S., 2018 – 2028 |
Figure 11‑6: Nerve Tube Market, U.S., 2018 – 2028 |
Figure 11‑7: Nerve Cap Market, U.S., 2018 – 2028 |
Figure 11‑8: Hospital Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑9: Non-Hospital Nerve Repair Market, U.S., 2018 – 2028 |
Figure 11‑10: Leading Competitors, Nerve Repair Market, U.S., 2021 |
Figure 12‑1: Cardiovascular Patch Repair Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑2: Cardiovascular Patch Repair Market by Material, U.S., 2018 – 2028 (US$M) |
Figure 12‑3: Cardiovascular Patch Repair Market, U.S., 2018 – 2028 |
Figure 12‑4: Cardiac Patch Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑5: Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑6: Allograft Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑7: Xenograft Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑8: Synthetic Cardiac Patch Market, U.S., 2018 – 2028 |
Figure 12‑9: Vascular Patch Market by Segment, U.S., 2018 – 2028 (US$M) |
Figure 12‑10: Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑11: Xenograft Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑12: Synthetic Vascular Patch Market, U.S., 2018 – 2028 |
Figure 12‑13: Leading Competitors, Cardiovascular Patch Repair Market, U.S., 2021 |
Figure 12‑14: Leading Competitors, Cardiac Patch Market by Material, U.S., 2021 |
Figure 12‑15: Leading Competitors, Vascular Patch Market by Material, U.S., 2021 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
Report Summary | FREE |
Soft Tissue Repair Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Breast Reconstruction Market, Hernia Repair Market, and 4 more
$7,995 – $9,995
iData’s full report suite on the U.S. market for soft tissue repair includes breast reconstruction, hernia repair, dural repair, dental soft tissue regeneration, nerve repair and cardiovascular patch repair.
- 2022
- 10 Years
- United States
- 06/17/2022
- 306
- MedSuite



